Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation

Blood

Volumn 94, Issue 3, 1999, Pages 1113-1120

  Kawano, Seiji ^a   Miller, Carl W ^b   Gombart, Adrian ^b   Bartram, Claus R ^b   Matsuo, Yoshinobu ^b   Asou, Hiroya ^b   Sakashita, Akiko ^b   Said, Jonathan ^b   Tatsumi, Eiji ^b   Koeffler, H Phillip ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; DNA METHYLATION; DNA POLYMORPHISM; GENE DELETION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOBLASTOMA; LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

DNA METHYLATION; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA; LYMPHOMA; NUCLEAR PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033179665     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hollstein M, Sidransky D, Vogelstein B, Hams C: p53 mutations in human cancers. Science 253:49, 1991
2. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453, 1991
3. Koeffler HP, Miller C, Nicolson MA, Ranyard J, Bosselman RA: Increased expression of p53 protein in human leukemia cells. Proc Natl Acad Sci USA 83:4035, 1986
4. Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ: Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 84:7716, 1987
5. Haffner R, Oren M: Biochemical properties and biological effects of p53. Curr Opin Genet Dev 5:84, 1995
6. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, Mckeon F, Caput D: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809, 1997
7. Jost CA, Marin MC, Kaelin WG Jr: p73 is a human p53-related protein that can induce apoptosis. Nature 389:191, 1997
8. Di Como CJ, Gaiddon C, Prives C: p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol Cell Biol 19:1438, 1999
9. Oren M: Lonely no more: p53 finds its kin in a tumor suppressor heaven. Cell 90:829, 1997
10. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R: p53 mutations in lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413, 1991
11. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JW, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, Lee E, Miyoshi I, Koeffler HP: Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 86:755, 1995
12. Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP: Homozygous deletions of the P15(MTS2) and p16(CDKN2/MTS1) genes in adult T-cell leukemia. Blood 85:2699, 1995
13. Ginsberg AM, Raffeld M, Cossman J: Inactivation of retinoblastoma gene in human lymphoid neoplasms. Blood 77:833, 1991
14. Diccianni MB, Yu J, Hsiao M, Mukherjee S, Shao LE, Yu AL: Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood 84:3105, 1994
15. Fizzotti M, Cimino G, Pisegna G, Alimena G, Quartarone C, Mandelli F, Pelicci PG, Lo Coco F: Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor(p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 85:2685, 1995
16. Sauerbrey A, Stammler G, Zintl F, Volm M: Expression and prognostic value of the retinoblastoma tumour suppressor gene(RB-1) in childhood acute lymphoblastic leukaemia. Br J Haematol 94:99, 1996
17. Ichikawa A, Kinoshita T, Watanabe T, Kato H, Nagai H, Tsushita K, Saito H, Hotta T: Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med 337:529, 1997
18. Villuendas R, Sanchez-Beato M, Martinez JC, Saez AI, Martinez-Delgado B, Garcia JF, Mateo MS, Sanchez-Verde L, Benitez J, Martinez P, Piris MA: Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression. Am J Pathol 153:887, 1998
19. Sanchez E, Chacon I, Plaza MM, Munoz E, Cruz MA, Martinez B, Lopez L, Martinez-Montero JC, Orradre JL, Saez AI, Garcia JF, Piris MA: Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins. J Clin Oncol 16:1931, 1998
20. Koeffler HP, Chen IS, Golde DW: Characterization of a novel HTLV-infected cell line. Blood 64:482, 1984
21. Koeffler HP, Golde DW: Acute myelogenous leukemia: A human cell line responsive to colony-stimulating activity. Science 200:1153, 1978
22. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, Wolf-Peeters CD, Falini B, Gatter KC, Grogan TM, Issacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warneke RA: A revised European-American Classification of Lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
23. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
24. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning. A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
25. Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI, Liu W: Activation of p73 silent allele in lung cancer. Cancer Res 58:2347, 1998
26. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T, Takahashi T: Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 58:1380, 1998
27. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1:686, 1995
28. Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Issacs WB, Sawyers CL: Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95:5246, 1998
29. Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voute PA, Westerveld A, Versteeg R: Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 4:187, 1993
30. Cheng JM, Hiemstra JL, Schneider SS, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM: Preferential amplification of the paternal allele of the N-myc gene in human neuroblastoma. Nat Genet 4:191, 1993
31. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE, Kefford RF: Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86:4614, 1989
32. Mori N, Morosetti R, Spira S, Lee S, Ben-Yehuda D, Schiller G, Landorfi R, Mizoguchi H, Koeffler HP: Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood 92:3405, 1998
33. Takahashi H, Ichimiya S, Nimura Y, Watanabe M, Furusato M, Wakui S, Yatani R, Aizawa S, Nakagawara A: Mutation, allelotyping, and transcription analysis of the p73 gene in prostatic carcinoma. Cancer Res 58:2076, 1998
34. Cheng J, Haas M: Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 10:5502, 1990
35. Kelman Z, Prokocimer M, Peller S, Kahn Y, Rechavi G, Manor Y, Cohen A, Rotter V: Rearrangement in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood 74:2318, 1989
36. Zhu XP, Dunn JM, Phillips RA, Goddard AD, Paton KE, Becker A, Gallie BL: Preferential germline mutation of the paternal allele in retinoblastoma. Nature 340:312, 1989
37. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA: Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55:4531, 1995
38. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers, Cancer Res 55:4525, 1995
39. Fueyo J, Gomez-Manzano C, Brunner JM, Saito Y, Zhang B, Zhang W, Levin VA, Yung WK, Kyritsis AP: Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas. Oncogene 13:1615, 1996
40. Tasaka T, Asou H, Munker R, Said JW, Berenson J, Nagai M, Takahara J, Koeffler HP: Hypermethylation of the p16INK4A gene in multiple myeloma. Br J Haematol 101:558, 1998
41. Ng MHL, Chung YF, Lo KW, Wickham NWR, Lee JCK, Huang DP: Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood 89:2500, 1997
42. Van Zee KJ, Calvano JE, Bisogna M: Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue. Oncogene 16:2723, 1998
43. Wong IH, Ng MH, Lee JC, Lo KW, Chung YF, Huang DP: Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation. BrJ Haematol 103:168, 1998